On-demand proton pump inhibitor therapy in patients with gastro-oesophageal reflux disease (Q35087701)

6 August 2017

1 reference

title

On-demand proton pump inhibitor therapy in patients with gastro-oesophageal reflux disease (English)

1 reference

6 August 2017

Pace F

1

1 reference

PubMed ID

12643297

6 August 2017

Pallotta S

series ordinal

2

1 reference

PubMed ID

12643297

6 August 2017

Bianchi Porro G

series ordinal

3

1 reference

6 August 2017

1 December 2002

1 reference

Digestive and Liver Disease

6 August 2017

1 reference

6 August 2017

34

1 reference

6 August 2017

12

1 reference

6 August 2017

870-877

1 reference

Opposing time trends of peptic ulcer and reflux disease

6 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980259-6

7 January 2021

The impact of gastroesophageal reflux disease on health-related quality of life.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980259-6

7 January 2021

Work loss costs due to peptic ulcer disease and gastroesophageal reflux disease in a health maintenance organization

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980259-6

7 January 2021

Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980259-6

7 January 2021

Meta-analysis of the effect of placebo on the outcome of medically treated reflux esophagitis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980259-6

7 January 2021

An evidence-based appraisal of reflux disease management--the Genval Workshop Report

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980259-6

7 January 2021

Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. The Practice Parameters Committee of the American College of Gastroenterology

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980259-6

7 January 2021

Three year follow up of patients with gastrooesophageal reflux disease

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980259-6

7 January 2021

On-demand treatment of gastro-oesophageal reflux symptoms: a comparison of ranitidine 75 mg with cimetidine 200 mg or placebo

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980259-6

7 January 2021

On demand therapy of reflux oesophagitis--a prospective study of symptoms, patient satisfaction and quality of life.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980259-6

7 January 2021

Symptomatic gastro-oesophageal reflux disease: double blind controlled study of intermittent treatment with omeprazole or ranitidine. The European Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980259-6

7 January 2021

On demand therapy with omeprazole for the long-term management of patients with heartburn without oesophagitis--a placebo-controlled randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980259-6

7 January 2021

Esomeprazole 20 mg maintains symptom control in endoscopy-negative gastro-oesophageal reflux disease: a controlled trial of 'on-demand' therapy for 6 months

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980259-6

7 January 2021

A cost-effectiveness analysis of prescribing strategies in the management of gastroesophageal reflux disease

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980259-6

7 January 2021

Effect of esomeprazole 40 mg vs omeprazole 40 mg on 24-hour intragastric pH in patients with symptoms of gastroesophageal reflux disease

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980259-6

7 January 2021

Pharmacokinetics and pharmacodynamics of esomeprazole, the S-isomer of omeprazole

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980259-6

7 January 2021

Review article: drug interactions with agents used to treat acid-related diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980259-6

7 January 2021

Long-term therapy of gastro-oesophageal reflux disease: medical or surgical?

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980259-6

7 January 2021

Improving opportunities for effective management of gastro-oesophageal reflux disease

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980259-6

7 January 2021

10.1016/S1590-8658(02)80259-6

Identifiers

DOI

1 reference

6 August 2017

1 reference

PubMed ID

12643297